| abstract |
The present disclosure relates to a use of Nocardia Rubra cell wall skeleton in regenerative medicine, and in particular, to a use of Nocardia Rubra (especially the cell wall skeleton thereof) in the following aspects: promoting proliferation, growth, differentiation and migration of stem cells, and improving the survival rate of the stem cells, wherein the stem cells are selected from: adult stem cells, iPSCs, and mesenchymal stem cells. |